Product Program year 2020 Source: CMS Open Payments

Intellis

Device Spinal Cord Neurostimulation

Open in the dashboard

General payments

$2,448,474

24,947 payments

Research payments

$1,689,752

242 payments

Through program year 2020, $2,448,474 in general payments and $1,689,752 in research payments were reported against Intellis (Spinal Cord Neurostimulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $1,297,474 10,223
2020 Research $739,041 112
2019 General $1,151,000 14,724
2019 Research $950,711 130

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic USA, Inc. $2,443,776 24,805 payments
  2. Medtronic, Inc. $4,539 136 payments
  3. Covidien LP $160 6 payments
Top recipients General payments · program year 2020
  1. Krishnan Chakravarthy Pain Medicine · Temecula, CA $93,222 7% · 111 payments
  2. Ricardo Vallejo Pain Medicine · Bloomington, IL $83,763 6% · 72 payments
  3. Michael Fishman Interventional Pain Medicine · Lebanon, PA $73,477 6% · 60 payments
  4. Michael Verdolin Interventional Pain Medicine · La Mesa, CA $44,754 3% · 67 payments
  5. Peter Staats Pain Medicine · Shrewsbury, NJ $30,260 2% · 13 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pain Medicine Anesthesiology $513,646 40% · 679 practitioners
  2. Interventional Pain Medicine Pain Medicine $319,074 25% · 513 practitioners
  3. Anesthesiology $101,843 8% · 237 practitioners
  4. Physical Medicine & Rehabilitation $69,787 5% · 204 practitioners
  5. Pain Medicine $69,613 5% · 161 practitioners

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $233,893 18% · 244 recipients
  2. Illinois $119,999 9% · 92 recipients
  3. Texas $91,483 7% · 365 recipients
  4. Pennsylvania $77,905 6% · 128 recipients
  5. Delaware $74,872 6% · 13 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

24,947 general · 242 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record